Revolutionizing Manufacturing to Make Gene Therapies Affordable

  • Forecasting next-generation technologies that could dramatically reduce production costs
  • Pinpointing remaining scientific and technical barriers to scalable manufacturing
  • Aligning innovation timelines with clinical and commercial readiness to support faster adoption